We gladly announce Heraeus as the exclusive licensee of our AGXX-Technology in form of particles. Based on the successful research and development work of the last years, Heraeus will now takeover the stalling and worldwide sales of our AGXX® technology in form of particles. We are humbled by the opportunity given hereby for us to contribute to the fight against many viruses such as the corona virus and harmful bacteria on a larger scale. With Heraeus taking over the responsibility for AGXX®  in form of particles, we will be able to focus our resources fully on further research and development of the AGXX® technology platform as well as the commercialization of the many more applications of AGXX®  that are in the pipeline already.